Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · see citing works

Co-Planar Stereotaxic Atlas of the Human Brain

Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798 · see citing works

Dissociable intrinsic connectivity networks for salience processing and executive control

Seeley, W. W., Menon, V., Schatzberg, A. F., Keller, J., Glover, G. H., Kenna, H., Reiss, A. L., & Greicius, M. D. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5587-06.2007 · Cited by 7,426 · see citing works

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology and pharmacology in schizophrenia

Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813 · see citing works

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · see citing works

The debate over dopamine’s role in reward: the case for incentive salience

Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347 · see citing works

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224 · see citing works

The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin

Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,953 · see citing works

The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis

D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024 · see citing works

Endogenous Potentials Generated in the Human Hippocampal Formation and Amygdala by Infrequent Events

Halgren, E., Squires, N. K., Wilson, C. L., Rohrbaugh, J., Babb, T. L., & Crandall, P. H. (1980) · Science · doi:10.1126/science.7434000 · Cited by 778 · see citing works

Adverse effects of cannabis

Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 778 · see citing works

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680 · see citing works

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617 · see citing works

Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects

Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608 · see citing works

Dose related risk of motor vehicle crashes after cannabis use

Ramaekers, J. G., Berghaus, G., van Laar, M., & Drummer, O. H. (2003) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.10.008 · Cited by 573 · see citing works

A cortical network sensitive to stimulus salience in a neutral behavioral context across multiple sensory modalities.

Downar, J., Crawley, A. P., Mikulis, D. J., & Davis, K. D. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00636.2001 · Cited by 544 · see citing works

Substantia nigra/ventral tegmental reward prediction error disruption in psychosis

Murray, G. K., Corlett, P. R., Clark, L., Pessiglione, M., Blackwell, A. D., Honey, G., Jones, P. B., Bullmore, E. T., Robbins, T. W., & Fletcher, P. C. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002058 · Cited by 532 · see citing works

From dopamine to salience to psychosis—Linking biology, pharmacology and phenomenology of psychosis

Kapur, S., Mizrahi, R., & Li, M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.01.003 · Cited by 512 · see citing works

Absolute Coding of Stimulus Novelty in the Human Substantia Nigra/VTA

Bunzeck, N., & Düzel, E. (2006) · Neuron · doi:10.1016/j.neuron.2006.06.021 · Cited by 503 · see citing works

Generic brain activation mapping in functional magnetic resonance imaging: A nonparametric approach

Brammer, M. J., Bullmore, E. T., Simmons, A., Williams, S., Grasby, P. M., Howard, R. J., Woodruff, P. W. R., & Rabe‐Hesketh, S. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(97)00135-5 · Cited by 470 · see citing works

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465 · see citing works

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

Zuardi, A. W. (2008) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462008000300015 · Cited by 421 · see citing works

Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications

Robbins, T. W. (2007) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2007.2097 · Cited by 413 · see citing works

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400001 · Cited by 402 · see citing works

Being stoned: a review of self‐reported cannabis effects

Green, B., Kavanagh, D. J., & Young, R. M. (2003) · Drug and Alcohol Review · doi:10.1080/09595230310001613976 · Cited by 390 · see citing works

Cognitive and subjective dose-response effects of acute oral Δ 9 -tetrahydrocannabinol (THC) in infrequent cannabis users

Curran, V. H., Brignell, C. M., Fletcher, S., Middleton, P. M., & Henry, J. A. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1169-0 · Cited by 370 · see citing works

Neurobiology of Dopamine in Schizophrenia

Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365 · see citing works

Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics

Juckel, G., Schlagenhauf, F., Koslowski, M., Filonov, D., Wüstenberg, T., Villringer, A., Knutson, B., Kienast, T., Gallinat, J., Wrase, J., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0405-4 · Cited by 323 · see citing works

Human striatal response to salient nonrewarding stimuli

Zink, C. F., Pagnoni, G., Martin, M. E., Dhamala, M., & Berns, G. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-22-08092.2003 · Cited by 312 · see citing works

Effects of cannabidiol (CBD) on regional cerebral blood flow

Crippa, J. A. D. S., Zuardi, A. W., Garrido, G. E. J., Wichert-Ana, L., Guarnieri, R., Ferrari, L., Azevedo-Marques, P. M., Hallak, J. E. C., McGuire, P. K., & Busatto, G. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300340 · Cited by 307 · see citing works

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

Karniol, I. G., Shirakawa, I., Kasinski, N., Pfeferman, A., & Carlini, E. A. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90129-0 · Cited by 303 · see citing works

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300 · see citing works

Effects of Acute Smoked Marijuana on Complex Cognitive Performance

Hart, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00273-1 · Cited by 272 · see citing works

Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum

Bossong, M., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R., Windhorst, A., van Gerven, J. V., Ramsey, N., Lammertsma, A., & Kahn, R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.138 · Cited by 262 · see citing works

Do patients with schizophrenia exhibit aberrant salience?

Roiser, J. P., Stephan, K. E., den Ouden, H. E. M., Barnes, T. R. E., Friston, K. J., & Joyce, E. M. (2009) · Psychological Medicine · doi:10.1017/s0033291708003863 · Cited by 262 · see citing works

Marijuana Intoxication : Common Experiences

TART, C. T. (1970) · Nature · doi:10.1038/226701a0 · Cited by 252 · see citing works

Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol

Bhattacharyya, S., Fusar‐Poli, P., Borgwardt, S., Martín‐Santos, R., Nosarti, C., O’Carroll, C., Allen, P., Seal, M. L., Fletcher, P. C., Crippa, J. A. S., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.17 · Cited by 246 · see citing works

The formation of abnormal associations in schizophrenia: Neural and behavioral evidence

Jensen, J., Willeit, M., Zipursky, R. B., Savina, I., Smith, A. J., Menon, M., Crawley, A. P., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301437 · Cited by 225 · see citing works

An event-related functional magnetic resonance imaging study of an auditory oddball task in schizophrenia

Kiehl, K. A., & Liddle, P. F. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00117-1 · Cited by 213 · see citing works

Human Hippocampal and Parahippocampal Activity during Visual Associative Recognition Memory for Spatial and Nonspatial Stimulus Configurations

Düzel, E., Habib, R., Rotte, M., Guderian, S., Tulving, E., & Heinze, H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09439.2003 · Cited by 211 · see citing works

Comparison of the subjective effects of Δ 9 -tetrahydrocannabinol and marijuana in humans

Wachtel, S. R., ElSohly, M. A., Ross, S. A., AMBRE, J. J., & de Wit, H. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1033-2 · Cited by 210 · see citing works

Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances

Ren, Y., Whittard, J., Higuera-Matas, A., Morris, C. V., & Hurd, Y. L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4291-09.2009 · Cited by 210 · see citing works

Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis

Morgan, C. J., Freeman, T. P., Schafer, G. L., & Curran, H. V. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.58 · Cited by 196 · see citing works

Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation

Chang, L., Yakupov, R., Cloak, C. C., & Ernst, T. (2006) · Brain · doi:10.1093/brain/awl064 · Cited by 189 · see citing works

Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs

Laviolette, S. R., & Grace, A. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0707-06.2006 · Cited by 189 · see citing works

Frontal Responses During Learning Predict Vulnerability to the Psychotogenic Effects of Ketamine: Linking Cognition, Brain Activity, and Psychosis

Corlett, P. R., Honey, G. D., Aitken, M. R. F., Dickinson, A., Shanks, D. R., Absalom, A. R., Lee, M., Pomarol-Clotet, E., Murray, G. K., McKenna, P. J., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.611 · Cited by 182 · see citing works

Effects of Smoking Marijuana on Brain Perfusion and Cognition

OʼLeary, D. S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00425-0 · Cited by 173 · see citing works

Human striatal activation reflects degree of stimulus saliency

Zink, C. F., Pagnoni, G., Chappelow, J., Martin-Skurski, M. E., & Berns, G. S. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.08.006 · Cited by 169 · see citing works

Temporal Lobe Dysfunction in Medication-Naïve Boys With Attention-Deficit/Hyperactivity Disorder During Attention Allocation and Its Relation to Response Variability

Rubia, K., Smith, A. B., Brammer, M. J., & Taylor, E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.024 · Cited by 168 · see citing works

Interhemispheric Integration: II. Symmetry and Convergence of the Corticostriatal Projections of the Left and the Right Principal Sulcus (PS) and the Left and the Right Supplementary Motor Area (SMA) of the Rhesus Monkey

McGuire, P. K., Bates, J. F., & Goldman‐Rakic, P. S. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.5.408 · Cited by 163 · see citing works

Effects of age and sex on developmental neural networks of visual–spatial attention allocation

Rubia, K., Hyde, Z., Halari, R., Giampietro, V., & Smith, A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.058 · Cited by 148 · see citing works

Effects of long-term cannabis use on selective attention: An event-related potential study

Solowij, N., Michie, P. T., & Fox, A. M. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90382-c · Cited by 124 · see citing works

Influence of cannabidiol on delta‐9‐tetrahydrocannabinol effects

Dalton, W. S., Martz, R. C., Lemberger, L., Rodda, B. E., & Forney, R. B. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976193300 · Cited by 123 · see citing works

Cocaine Decreases Cortical Cerebral Blood Flow but Does Not Obscure Regional Activation in Functional Magnetic Resonance Imaging in Human Subjects

Gollub, R. L., Breiter, H. C., Kantor, H. L., Kennedy, D. N., Gastfriend, D. R., Mathew, R. T., Makris, N., Guimarães, A. R., Riorden, J., Campbell, T., et al. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199807000-00003 · Cited by 120 · see citing works

Adaptive anterior hippocampal responses to oddball stimuli

Strange, B. A., & Dolan, R. J. (2001) · Hippocampus · doi:10.1002/hipo.1084 · Cited by 117 · see citing works

Cannabinoid Agonists but not Inhibitors of Endogenous Cannabinoid Transport or Metabolism Enhance the Reinforcing Efficacy of Heroin in Rats

Solinas, M., Panlilio, L. V., Tanda, G., Makriyannis, A., Matthews, S. A., & Goldberg, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300754 · Cited by 96 · see citing works

Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats

Malone, D. T., Jongejan, D., & TAYLOR, D. A. H. B. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.010 · Cited by 91 · see citing works

Effects of acute oral Δ9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers

Roser, P., Juckel, G., Rentzsch, J., Nadulski, T., Gallinat, J., & Stadelmann, A. M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.04.008 · Cited by 88 · see citing works

Coupling of regional activations in a human brain during an object and face affect recognition task

Ioannides, A. A., Liu, L. C., Kwapień, J., Drożdż, S., & Streit, M. (2000) · Human Brain Mapping · doi:10.1002/1097-0193(200010)11:2 · Cited by 85 · see citing works

Exposure to Δ-9-Tetrahydrocannabinol (THC) Increases Subsequent Heroin Taking but not Heroin's Reinforcing Efficacy: A Self-Administration Study in Rats

Solinas, M., Panlilio, L. V., & Goldberg, S. R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300431 · Cited by 85 · see citing works

Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms

Morrison, P. D., Nottage, J. F., Stone, J. M., Bhattacharyya, S., Tunstall, N., Brenneisen, R., Holt, D., Wilson, D., Sumich, A. L., McGuire, P. K., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.222 · Cited by 82 · see citing works

Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge

Stokes, P. R. A., Egerton, A., Watson, B., Reid, A., Breen, G., Lingford-Hughes, A., Nutt, D., & Mehta, M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.274 · Cited by 75 · see citing works

Influence of marijuana on driving

Robbe, H. W. J. (1994) · doi:10.26481/dis.19940526hr · Cited by 74 · see citing works

Acute marijuana effects on rCBF and cognition

OʼLeary, D. S., Block, R. I., Flaum, M., Schultz, S. K., Ponto, L. L. B., Watkins, G. L., Hurtig, R. R., Andreasen, N. C., & Hichwa, R. D. (2000) · Neuroreport · doi:10.1097/00001756-200011270-00047 · Cited by 64 · see citing works

Characterization of effects of mean arterial blood pressure induced by cocaine and cocaine methiodide on BOLD signals in rat brain

Luo, F. R., Wu, G., Li, Z., & Li, S. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10366 · Cited by 63 · see citing works

THE INFLUENCE OF CANNABIS ON DRIVING

Sexton, B. F., Tunbridge, R. J., Brook-Carter, N., Jackson, P. G., Wright, K. A., Stark, M. M., & Englehart, K. (2000) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 51 · see citing works

Dose‐dependent effects of Δ9‐tetrahydrocannabinol on rates of local cerebral glucose utilization in rat

Freedland, C. S., Whitlow, C. T., Miller, M. D., & Porrino, L. J. (2002) · Synapse · doi:10.1002/syn.10089 · Cited by 48 · see citing works

Hippocampal involvement in detection of deviant auditory and visual stimuli

Crottaz‐Herbette, S., Lau, K. M., Glover, G. H., & Menon, V. (2004) · Hippocampus · doi:10.1002/hipo.20039 · Cited by 39 · see citing works

Effect of Acute Marijuana on Cardiovascular Function and Central Nervous System Pharmacokinetics of [15O]Water: Effect in Occasional and Chronic Users

Ponto, L. L. B., OʼLeary, D. S., Koeppel, J. A., Block, R. I., Watkins, G. L., Richmond, J. C. W., Ward, C. A., Clermont, D., Schmitt, B., & Hichwa, R. D. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004265699 · Cited by 31 · see citing works

A Validation of Event-Related fMRI Comparisons Between Users of Cocaine, Nicotine, or Cannabis and Control Subjects

Murphy, K., Dixon, V., LaGrave, K., Kaufman, J. N., Risinger, R. C., Bloom, A. S., & Garavan, H. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.7.1245 · Cited by 29 · see citing works

The Cannabis Experience: An Interpretative Study of the Effects of Marijuana and Hashish

Joseph, J., Berke, C. C. H., & Berke, J. H. (1974) · Cited by 8 · see citing works

ABERRANT SALIENCE IN SUBJECTS AT HIGH RISK OF PSYCHOSIS RELATED TO ALTERED DORSOLATERAL PREFRONTAL FUNCTION

Roiser, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.191 · Cited by 2 · see citing works

Untitled work

Liddle (2001) · doi:10.1002/1097-0193(200102)12:2

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475 · see citing works

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

Englund, A., Morrison, P. D., Nottage, J. F., Hague, D., Kane, F., Bonaccorso, S., Stone, J. M., Reichenberg, A., Brenneisen, R., Holt, D., et al. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112460109 · Cited by 462 · see citing works

Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings

Batalla, A., Bhattacharyya, S., Yücel, M., Fusar‐Poli, P., Crippa, J. A. S., Nogué, S., Torrens, M., Pujol, J., Farré, M., & Martín‐Santos, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055821 · Cited by 416 · see citing works

Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial

Hurd, Y. L., Spriggs, S. A., Alishayev, J., Winkel, G. H., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E. A. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101191 · Cited by 344 · see citing works

Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia

Sarpal, D. K., Robinson, D. G., Lencz, T., Árgyelán, M., Ikuta, T., Karlsgodt, K. H., Gallego, J. A., Kane, J. M., Szeszko, P. R., & Malhotra, A. K. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1734 · Cited by 328 · see citing works

Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis

Schoeler, T., Monk, A., Sami, M. B., Klamerus, E., Foglia, E., Brown, R., Camuri, G., Altamura, A. C., Murray, R., & Bhattacharyya, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00363-6 · Cited by 322 · see citing works

Gone to Pot – A Review of the Association between Cannabis and Psychosis

Radhakrishnan, R., Wilkinson, S. T., & Dâ€TMSouza, D. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00054 · Cited by 313 · see citing works

Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences

Crane, N. A., Schuster, R. M., Fusar‐Poli, P., & González, R. (2012) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 310 · see citing works

Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age

Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308 · see citing works

A systematic review of the antipsychotic properties of cannabidiol in humans

Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261 · see citing works

Involvement of the dorsal and ventral attention networks in oddball stimulus processing: A meta‐analysis

Kim, H. (2013) · Human Brain Mapping · doi:10.1002/hbm.22326 · Cited by 237 · see citing works

The neuropsychopharmacology of cannabis: A review of human imaging studies

Bloomfield, M., Hindocha, C., Green, S. F., Wall, M. B., Lees, R., Petrilli, K., Costello, H., Ogunbiyi, O., Bossong, M. G., & Freeman, T. P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.006 · Cited by 238 · see citing works

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Waldo Zuardi, A., Alexandre S. Crippa, J., E.C. Hallak, J., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., K. McGuire, P., & Silveira Guimaraes, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884681 · Cited by 222 · see citing works

Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects

Hurd, Y. L., Manzoni, O. J., Pletnikov, M. V., Lee, F. S., Bhattacharyya, S., & Melis, M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1165-19.2019 · Cited by 218 · see citing works

Cannabis-associated psychosis: Neural substrate and clinical impact

Murray, R. M., Englund, A., Abi‐Dargham, A., Lewis, D. A., Forti, M. D., Davies, C., Sherif, M. A., McGuire, P. K., & D’Souza, D. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.018 · Cited by 201 · see citing works

Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective

Cohen, K., & Weinstein, A. M. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00162 · Cited by 197 · see citing works

The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task

MTAC, Wilson, R. P., Colizzi, M., Bossong, M. G., Allen, P., Kempton, M. J., & Bhattacharyya, S. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9385-5 · Cited by 186 · see citing works

Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile

Swift, W., Wong, A. C. H., Li, K. M., Arnold, J. C., & McGregor, I. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070052 · Cited by 182 · see citing works

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

Bonaccorso, S., Ricciardi, A., Zangani, C., Chiappini, S., & Schifano, F. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.002 · Cited by 170 · see citing works

Altered Striatal Functional Connectivity in Subjects With an At-Risk Mental State for Psychosis

Dandash, O., Fornito, A., Lee, J., Keefe, R. S. E., Chee, M. W. L., Adcock, R. A., Pantelis, C., Wood, S. J., & Harrison, B. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt093 · Cited by 161 · see citing works

Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study

Schoeler, T., Petros, N., Forti, M. D., Klamerus, E., Foglia, E., Ajnakina, O., Gayer-Anderson, C. E., Colizzi, M., Quattrone, D., Behlke, I., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30188-2 · Cited by 162 · see citing works

Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis

Bhattacharyya, S., Wilson, R. P., Appiah‐Kusi, E., O’Neill, A., Brammer, M. J., Pérez, J., Murray, R. M., Allen, P., Bossong, M. G., & McGuire, P. K. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2309 · Cited by 151 · see citing works

Therapeutic potential of cannabis-related drugs

Alexander, S. P. H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.001 · Cited by 149 · see citing works

Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence

Colizzi, M., McGuire, P. K., Pertwee, R. G., & Bhattacharyya, S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.010 · Cited by 146 · see citing works

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition

Colizzi, M., & Bhattacharyya, S. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0142-2 · Cited by 138 · see citing works

Heavy cannabis use, dependence and the brain: a clinical perspective

Kroon, E., Kuhns, L., Hoch, E., & Cousijn, J. (2019) · Addiction · doi:10.1111/add.14776 · Cited by 130 · see citing works

Impact of Cannabis Use on the Development of Psychotic Disorders

Wilkinson, S. T., Radhakrishnan, R., & D’Souza, D. C. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0018-7 · Cited by 131 · see citing works

Human Laboratory Studies on Cannabinoids and Psychosis

Sherif, M. A., Radhakrishnan, R., D’Souza, D. C., & Ranganathan, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.011 · Cited by 122 · see citing works

Therapeutic potential of cannabinoid medicines

Robson, P. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1529 · Cited by 124 · see citing works

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis.

Rubio, J., Schoretsanitis, G., John, M., Tiihonen, J., Taipale, H., Guinart, D., Malhotra, A., Correll, C., & Kane, J. (2020) · Lancet psychiatry · doi:10.1016/s2215-0366(20)30264-9 · Cited by 96 · see citing works

Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience

Bhattacharyya, S., Falkenberg, I., Martín‐Santos, R., Atakan, Z., Crippa, J. A. S., Giampietro, V., Brammer, M. J., & McGuire, P. K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.258 · Cited by 112 · see citing works

Marijuana: Current Concepts†

Greydanus, D. E., Hawver, E. K., Greydanus, M. M., & Merrick, J. (2013) · Frontiers in Public Health · doi:10.3389/fpubh.2013.00042 · Cited by 112 · see citing works

Cannabidiol as a potential treatment for psychosis

Davies, C., & Bhattacharyya, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319881916 · Cited by 113 · see citing works

Changes in cannabis use among young people

Copeland, J., Rooke, S. E., & Swift, W. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328361eae5 · Cited by 111 · see citing works

Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches

Cadet, J. L., & Bisagno, V. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00189 · Cited by 110 · see citing works

Is cannabis neurotoxic for the healthy brain? A meta‐analytical review of structural brain alterations in non‐psychotic users

Rocchetti, M., Crescini, A., Borgwardt, S., Caverzasi, E., Politi, P., Atakan, Z., & Fusar‐Poli, P. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12085 · Cited by 103 · see citing works

Cannabidiol as a potential treatment for psychosis

Schubart, C. D., Sommer, I. E., Fusar‐Poli, P., de Witte, L. D., Kahn, R. S., & Boks, M. P. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.002 · Cited by 100 · see citing works

Cannabis use and transition to psychosis in people at ultra-high risk

Valmaggia, L., Day, F., Jones, C., Bissoli, S., Pugh, C., Hall, D., Bhattacharyya, S., Howes, O. D., Stone, J. M., Fusar‐Poli, P., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291714000117 · Cited by 97 · see citing works

Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments

Renard, J., Norris, C., Rushlow, W. J., & Laviolette, S. R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.006 · Cited by 97 · see citing works

Effects of Cannabis on Impulsivity: A Systematic Review of Neuroimaging Findings

Wrege, J. S., Schmidt, A., Walter, A., Smieskova, R., Bendfeldt, K., Radue, E. W., Lang, U. E., & Borgwardt, S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990428 · Cited by 94 · see citing works

Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis

Appiah‐Kusi, E., Petros, N., Wilson, R. J., Colizzi, M., Bossong, M. G., Valmaggia, L., Mondelli, V., McGuire, P. K., & Bhattacharyya, S. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05442-6 · Cited by 93 · see citing works

Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity

Wall, M. B., Pope, R. A., Freeman, T. P., Kowalczyk, O. S., Demetriou, L., Mokrysz, C., Hindocha, C., Lawn, W., Bloomfield, M., Freeman, A. M., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119841568 · Cited by 92 · see citing works

Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review

Batalla, A., Crippa, J. A., Busatto, G. F., Guimaraes, F. S., Zuardi, A. W., Valverde, O., Atakan, Z., McGuire, P. K., Bhattacharyya, S., & Martín-Santos, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990432 · Cited by 91 · see citing works

Modulatory effects of cannabinoids on brain neurotransmission

Cohen, K., Weizman, A., & Weinstein, A. M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14407 · Cited by 92 · see citing works

Residual effects of cannabis use in adolescent and adult brains — A meta-analysis of fMRI studies

Blest‐Hopley, G., Giampietro, V., & Bhattacharyya, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.008 · Cited by 89 · see citing works

Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation

Hudson, R., Renard, J., Norris, C., Rushlow, W. J., & Laviolette, S. R. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0708-19.2019 · Cited by 86 · see citing works

Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence

Blest‐Hopley, G., Colizzi, M., Giampietro, V., & Bhattacharyya, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00859 · Cited by 85 · see citing works

Continuity of cannabis use and violent offending over the life course

Schoeler, T., Theobald, D., Pingault, J., Farrington, D. P., Jennings, W. G., Piquero, A. R., Coid, J., & Bhattacharyya, S. (2016) · Psychological Medicine · doi:10.1017/s0033291715003001 · Cited by 82 · see citing works

Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review

SANTOS, R. G. D., Hallak, J. E. C., & Crippa, J. A. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_3 · Cited by 82 · see citing works

Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis

Bhattacharyya, S., Atakan, Z., Martín‐Santos, R., Crippa, J. A. S., Kambeitz, J. P., Malhi, S., Giampietro, V., Williams, S., Brammer, M. J., Rubia, K., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.018 · Cited by 78 · see citing works

Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing

Yanes, J. A., Riedel, M. C., Ray, K. L., Kirkland, A. E., Bird, R. T., Boeving, E. R., Reid, M. A., González, R., Robinson, J. L., Laird, A. R., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117744995 · Cited by 77 · see citing works

Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis

O’Neill, A., Wilson, R. P., Blest‐Hopley, G., Annibale, L., Colizzi, M., Brammer, M. J., Giampietro, V., & Bhattacharyya, S. (2020) · Psychological Medicine · doi:10.1017/s0033291719003519 · Cited by 75 · see citing works

Acute and Non-acute Effects of Cannabis on Human Memory Function: A Critical Review of Neuroimaging Studies

Bossong, M. G., Jager, G., Bhattacharyya, S., & Allen, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990436 · Cited by 73 · see citing works

Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System

Norris, C., Loureiro, M., Kramar, C. P., Zunder, J. S., Renard, J., Rushlow, W. J., & Laviolette, S. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.93 · Cited by 75 · see citing works

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis

Colizzi, M., Weltens, N., McGuire, P. K., Lythgoe, D. J., Williams, S., Oudenhove, L. V., & Bhattacharyya, S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0374-8 · Cited by 74 · see citing works

The why behind the high: determinants of neurocognition during acute cannabis exposure

Ramaekers, J. G., Mason, N. L., Kloft, L., & Theunissen, E. L. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00466-4 · Cited by 73 · see citing works

Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors

Bhattacharyya, S., Egerton, A., Kim, E., Rosso, L., Barros, D. A. R., Hammers, A., Brammer, M. J., Turkheimer, F., Howes, O. D., & McGuire, P. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-14203-4 · Cited by 73 · see citing works

Cannabis and Driving

Pearlson, G. D., Stevens, M. C., & D'Souza, D. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.689444 · Cited by 72 · see citing works

Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study

Leehey, M. A., Liu, Y., Hart, F., Epstein, C. H., Cook, M., Sillau, S., Klawitter, J., Newman, H., Sempio, C., Forman, L., et al. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0068 · Cited by 69 · see citing works

The Impact of Cannabidiol on Human Brain Function: A Systematic Review

Batalla, A., Bos, J., Postma, A., & Bossong, M. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618184 · Cited by 69 · see citing works

Cannabis Abstinence During Treatment and One-Year Follow-Up: Relationship to Neural Activity in Men

Hedy Kober, A., DeVito, E. E., DeLeone, C. M., Carroll, K. M., & Potenza, M. N. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.82 · Cited by 62 · see citing works

Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals

Vlachou, S., & Panagis, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990433 · Cited by 60 · see citing works

Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date.

Sami, M., Rabiner, E., & Bhattacharyya, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.011 · Cited by 68 · see citing works

Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity

Grimm, O., Löffler, M., Kamping, S., Hartmann, A., Rohleder, C., Leweke, F. M., & Flor, H. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.04.004 · Cited by 60 · see citing works

Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).

Bossong, M., Jansma, J., Bhattacharyya, S., & Ramsey, N. (2014) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.017 · Cited by 58 · see citing works

Green tea extract enhances parieto-frontal connectivity during working memory processing

Schmidt, A., Hammann, F., Wölnerhanssen, B., Meyer-Gerspach, A. C., Drewe, J., Beglinger, C., & Borgwardt, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3526-1 · Cited by 57 · see citing works

Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing in dependent marijuana users after 28 days of abstinence

Zimmermann, K., Yao, S., Heinz, M., Zhou, F., Dau, W., Banger, M., Weber, B., Hurlemann, R., & Becker, B. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4803-6 · Cited by 51 · see citing works

Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers

Atakan, Z., Bhattacharyya, S., Allen, P., Martín‐Santos, R., Crippa, J. A. S., Borgwardt, S., Fusar‐Poli, P., Seal, M. L., Sallis, H., Stahl, D. R., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712001924 · Cited by 56 · see citing works

Effects of Cannabis Use on Human Brain Structure in Psychosis: A Systematic Review Combining In Vivo Structural Neuroimaging and Post Mortem Studies

Rapp, C., Bugra, H., Riecher‐Rössler, A., Tamagni, C., & Borgwardt, S. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884861 · Cited by 55 · see citing works

Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis

van Winkel, R., & Kuepper, R. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153631 · Cited by 53 · see citing works

An introduction to psychedelic neuroscience

Calvey, T., & Howells, F. M. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.09.013 · Cited by 49 · see citing works

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition

Colizzi, M., Ruggeri, M., & Bhattacharyya, S. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00833 · Cited by 50 · see citing works

The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review

James, A. C., James, C., & Thwaites, T. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.07.012 · Cited by 50 · see citing works

Terminology and assessment tools of psychosis: A systematic narrative review

Seiler, N., Nguyen, T., Yung, A. R., & O'Donoghue, B. N. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12966 · Cited by 49 · see citing works

Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids

Appiah‐Kusi, E., Leyden, E., Parmar, S. R., Mondelli, V., McGuire, P. K., & Bhattacharyya, S. (2015) · Psychological Medicine · doi:10.1017/s0033291715001786 · Cited by 45 · see citing works

Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders

Sami, M. B., & Bhattacharyya, S. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118760662 · Cited by 45 · see citing works

Neural effects of green tea extract on dorsolateral prefrontal cortex

Borgwardt, S., Hammann, F., Scheffler, K., Kreuter, M., Drewe, J., & Beglinger, C. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.105 · Cited by 43 · see citing works

Cannabidiol (CBD) as a novel treatment in the early phases of psychosis

Chesney, E., Oliver, D., & McGuire, P. (2022) · Psychopharmacology · doi:10.1007/s00213-021-05905-9 · Cited by 40 · see citing works

Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms

Carvalho, A. C., & Vieira‐Coelho, M. A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106258 · Cited by 40 · see citing works

Dopamine modulates processing speed in the human mesolimbic system

Eckart, C., & Bunzeck, N. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.11.001 · Cited by 40 · see citing works

fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy

Allendorfer, J. B., Nenert, R. E., Bebin, E. M., Gaston, T. E., Grayson, L. E., Hernando, K. A., Houston, J. T., Hansen, B., & Szaflarski, J. P. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.04.008 · Cited by 40 · see citing works

The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study

Bloomfield, M., Green, S. F., Hindocha, C., Yamamori, Y., Yim, J. L., Jones, A., Walker, H. R., Tokarczuk, P. F., Statton, B. K., Howes, O. D., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120936419 · Cited by 40 · see citing works

Cannabis and psychosis: Have we found the missing links?

Parakh, P., & Basu, D. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.03.012 · Cited by 39 · see citing works

Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology

Hudson, R., Rushlow, W. J., & Laviolette, S. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4766-7 · Cited by 33 · see citing works

Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control

Bhattacharyya, S., Iyegbe, C. O., Atakan, Z., Martín‐Santos, R., Crippa, J. A. S., Xu, X., Williams, S., Brammer, M. J., Rubia, K., Prata, D. P., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291714000920 · Cited by 38 · see citing works

A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis

Davies, C., Wilson, R. P., Appiah‐Kusi, E., Blest‐Hopley, G., Brammer, M. J., Pérez, J., Murray, R. M., Allen, P., Bossong, M. G., McGuire, P. K., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0862-2 · Cited by 38 · see citing works

Cannabidiol modulation of hippocampal glutamate in early psychosis

O’Neill, A., Annibale, L., Blest‐Hopley, G., Wilson, R. P., Giampietro, V., & Bhattacharyya, S. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211001107 · Cited by 37 · see citing works

The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability

Løberg, E., Helle, S., Nygård, M., Berle, J. Ø., Kroken, R. A., & Johnsen, E. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00159 · Cited by 37 · see citing works

Modulation of brain structure by catechol‐ O ‐methyltransferase Val158Met polymorphism in chronic cannabis users

Batalla, A., Soriano‐Mas, C., López‐Solà, M., Torrens, M., Crippa, J. A., Bhattacharyya, S., Blanco‐Hinojo, L., Fagundo, A. B., Harrison, B. J., Nogué, S., et al. (2013) · Addiction Biology · doi:10.1111/adb.12027 · Cited by 37 · see citing works

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research

Ruggiero, R. N., Rossignoli, M. T., Ross, J. B. D., Hallak, J. E. C., Leite, J. P., & Bueno-Júnior, L. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00399 · Cited by 37 · see citing works

The effects of cannabis use on salience attribution: a systematic review

Wijayendran, S. B., O’Neill, A., & Bhattacharyya, S. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.58 · Cited by 35 · see citing works

Brain Mapping-Based Model of Δ9-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix

Walter, C., Oertel, B. G., Felden, L., Kell, C. A., Nöth, U., Vermehren, J., Kaiser, J., Deichmann, R., & Lötsch, J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.336 · Cited by 34 · see citing works

Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study

Vadhan, N. P., Corcoran, C. M., Bedi, G., Keilp, J. G., & Haney, M. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.070 · Cited by 34 · see citing works

A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations

Blest-Hopley, G., Giampietro, V., & Bhattacharyya, S. (2020) · Brain Science · doi:10.3390/brainsci10020102 · Cited by 27 · see citing works

Cannabinoids, reward processing, and psychosis

Gunasekera, B., Diederen, K. M. J., & Bhattacharyya, S. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05801-2 · Cited by 33 · see citing works

Dose–response effect between cannabis use and psychosis liability in a non-clinical population: Evidence from a snowball sample

Ruíz-Veguilla, M., Barrigón, M. L., Hernández, L., Rubio, J. L., Manuel Gurpegui, A., Sarramea, F., Cervilla, J. A., Gutiérrez, B., James, A. C., & Ferrín, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.003 · Cited by 33 · see citing works

Cannabinoid Modulation of Frontolimbic Activation and Connectivity During Volitional Regulation of Negative Affect

Gorka, S. M., Phan, K. L., Lyons, M., Mori, S., Angstadt, M., & Rabinak, C. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.359 · Cited by 33 · see citing works

Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry

Calapai, G., Mannucci, C., Chinou, İ., Cardia, L., Calapai, F., Sorbara, E. E., Firenzuoli, B., Ricca, V., Gensini, G. F., & Firenzuoli, F. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2509129 · Cited by 34 · see citing works

Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy

Allendorfer, J. B., & Szaflarski, J. P. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.11.020 · Cited by 32 · see citing works

Dopamine Controls the Neural Dynamics of Memory Signals and Retrieval Accuracy

Apitz, T., & Bunzeck, N. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.141 · Cited by 30 · see citing works

Induction of Psychosis by Delta 9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

Bhattacharyya, S., Crippa, J. A., Allen, P., Martín‐Santos, R., Borgwardt, S., Fusar‐Poli, P., Rubia, K., Kambeitz, J., O’Carroll, C., Seal, M. L., et al. (2012) · Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) · Cited by 8 · see citing works

ORIGINAL ARTICLE Induction of Psychosis by 9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

(2015)

Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience

Bhattacharyya, S., Falkenberg, I., Martín‐Santos, R., Atakan, Z., Crippa, J. A. S., Giampietro, V., Brammer, M. J., & McGuire, P. K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.258 · Cited by 112 · see citing works

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680 · see citing works

The effects of cannabis use on salience attribution: a systematic review

Wijayendran, S. B., O’Neill, A., & Bhattacharyya, S. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.58 · Cited by 35 · see citing works